Andrew Curtis brings more than ten years of pharmaceutical experience, joining Jerini after three years at Pfizer, where he most recently served as U.S. Marketing Director for ARICEPT. Curtis began his pharmaceutical career at Aventis and has held marketing and sales positions at Merck, Genzyme, and J&J. In his previous positions, he successfully managed product filings and launches, and gained expertise in the areas of orphan drugs and rare genetic diseases, metabolic bone disease, burn treatment, and vaccine therapy.